DV
Dividend Vision

VCYT — Veracyte, Inc.

Veracyte, Inc. (VCYT)

Total return is 211.3% over the past 12.8 years, 235.2 points behind SPY at 446.5%. Its deepest 1-year drawdown was 39.2%.

VCYT is a single-stock equity holding in Veracyte, Inc., a diagnostics and genomics company. The stock does not currently pay distributions and carries no expense ratio as it is a direct equity position rather than a diversified fund. This holding appeals primarily to growth-oriented investors seeking exposure to the precision medicine and molecular diagnostics sector.

VCYT key facts

Asset type
Stock
Asset class
Equity
Inception date
10/30/2013
Distribution frequency
None
Last close
$41.25
Market cap
$3,316,117,504
Average volume
1668000.0
Beta
1.94
Payout ratio
0.0
P/E ratio
29.4643
Forward P/E
25.5754
EPS
$1.40